| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 07/25/2006 | US7081242 Administering conjugate comprising (a) a non-immunogenic valency platform molecule and (b) two or more molecules comprising double stranded DNA (dsDNA) epitopes, wherein the dsDNA epitopes are polynucleotides which specifically bind to an antibody from the individual |
| 07/25/2006 | US7081240 Protein mixtures for wound healing |
| 07/25/2006 | CA2207652C Hemolysis prevention by surfactants and emulsions |
| 07/21/2006 | CA2494209A1 Radiosensitizer formulations and methods for use |
| 07/20/2006 | WO2006076673A2 Use of il-i antagonists to treat polymyalgia rheumatica and giant cell arteritis |
| 07/20/2006 | WO2006076124A2 Stable, non-crystalline formulation comprising olanzapine |
| 07/20/2006 | WO2006076042A2 Novel hydrogels and uses thereof |
| 07/20/2006 | WO2006075743A1 O/w emulsion composition |
| 07/20/2006 | WO2006075690A1 Stable medicinal composition |
| 07/20/2006 | WO2006075170A1 Meningococcal conjugate vaccination |
| 07/20/2006 | WO2006074872A1 Intravenous formulations of pde-5 inhibitors |
| 07/20/2006 | WO2006074600A1 Modified exendins and uses thereof |
| 07/20/2006 | WO2006074546A1 Lipid encapsulated interfering rna |
| 07/20/2006 | WO2006042858A3 Complex comprising an antibiotic, a cyclodextrin and an interaction agent |
| 07/20/2006 | WO2006034455A3 Polipeptide compounds for inhibiting angiogenesis and tumor growth |
| 07/20/2006 | WO2006020743A3 Heat shock protein as a targeting agent for endothelium-specific in vivo transduction |
| 07/20/2006 | WO2006004577A3 Lubricant for the ocular surface |
| 07/20/2006 | WO2005120487A3 Preparation for the prevention and treatment of stress conditions as well as functional and organic disorders of the nervous system and metabolic disorders |
| 07/20/2006 | WO2005117983A3 Carrier conjugates of tnf-peptides |
| 07/20/2006 | WO2005105148A3 Liquid growth hormone formulation |
| 07/20/2006 | WO2005092391A3 Conjugates of hydroxyalkyl starch and a protein |
| 07/20/2006 | WO2005077422B1 Antibody linked cationic emulsions as drug delivery system |
| 07/20/2006 | WO2005075021A3 Chemically-modified human growth hormone receptor antagonist conjugates |
| 07/20/2006 | WO2004080413A3 Uses and formulations for transdermal or transmucosal application of active agents |
| 07/20/2006 | US20060160997 Tumor-associated antigen specific immunoglobulin fusion for use in diagnosis, prevention and treatment of cell proliferative |
| 07/20/2006 | US20060160768 Novel polysaccharides with antithrombotic activity comprising at least one covalent bond with biotin or a biotin derivative |
| 07/20/2006 | US20060160754 Glycyrrhizin high-concentration preparation |
| 07/20/2006 | US20060160746 Amino acid and peptide conjugates of amiloride and methods of use thereof |
| 07/20/2006 | US20060160739 GRF-containing lyophilized pharmaceutical compositions |
| 07/20/2006 | US20060160732 Compositions and methods for inhibiting cell senescence and hyperproliferative disorders |
| 07/20/2006 | US20060160719 Flavor and fragrance compositions |
| 07/20/2006 | US20060160246 Graphitic nanotubes in luminescence assays |
| 07/20/2006 | US20060160194 Process for the production of biodegradeable, functionalised polymer particles, and use thereof as pharmaceutical supports |
| 07/20/2006 | US20060160123 For increasing stability of short interfering RNA molecule when in contact with biological sample, and reducing off-target effects/interferon responsiveness; ribonuclease stability |
| 07/20/2006 | US20060159782 Material for promoting skin basement formation |
| 07/20/2006 | US20060159769 Methods compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissue |
| 07/20/2006 | US20060159768 Quetiapine granules |
| 07/20/2006 | US20060159764 for delivery of nucleic acids for example; noncovalently associating molecules with the polyion in a solution outside a cell; adding a crosslinker that contains a disulfide bond and forms covalent linkages between moieties of the molecules in the presence of the polyion, to form a complex |
| 07/20/2006 | US20060159761 for therapy of allergic and/or inflammatory conditions of the skin and airway passages; desloratadine-pseudoephedrine once-a-day product which produces a release rate profile for pseudoephedrine over an extended period in excess of twelve hours while maintaining delivery of desloratadine |
| 07/20/2006 | US20060159755 Method for producing a controlled release preparation |
| 07/20/2006 | US20060159749 Mesalamine inglobated in a three-component matrix structure, i.e. a structure formed by successive amphiphilic, lipophilic or inert matrices and finally inglobated or dispersed in hydrophilic matrices |
| 07/20/2006 | US20060159725 Herbal compositions |
| 07/20/2006 | US20060159724 Nutritional supplement for the management of weight |
| 07/20/2006 | US20060159715 Conjugate of fine porous particles with polymer molecules and the utilization thereof |
| 07/20/2006 | US20060159687 Modified aerolysin and methods of use for treating lung cancer |
| 07/20/2006 | US20060159682 Monoclonal antibodies (MAbs) against tumor-associated antigens, the preparation and use thereof |
| 07/20/2006 | US20060159679 Stabilized lyophilized compositions comprising tissue factor pathway inhibitor or tissue factor pathway inhibitor variants |
| 07/20/2006 | US20060159677 Tumour necrosis factor peptide binding antibodies |
| 07/20/2006 | US20060159669 Novel uses of PPAR modulators and professional APCs manipulated by the same |
| 07/20/2006 | US20060159657 Formulations of lymphokines and method of use thereof for local or both local and systemic control of proliferative cell disorders |
| 07/20/2006 | US20060159656 Formulations for IL-11 |
| 07/20/2006 | US20060159653 Stabilized preparation containing protein |
| 07/20/2006 | US20060159638 O/W emulsions comprising micronized biologically active agents |
| 07/20/2006 | US20060159633 emulsive water-soluble concentrates |
| 07/20/2006 | US20060159632 Drug formulation for mouth or pharynx comprising local anesthetic |
| 07/20/2006 | US20060159629 Perforated; standard particle size; nonaggregating; flowability, dispersibility; lower dosage inhalants |
| 07/20/2006 | US20060158725 Laser projector |
| 07/20/2006 | CA2603630A1 Modified exendins and uses thereof |
| 07/20/2006 | CA2595128A1 Meningococcal conjugate vaccination |
| 07/20/2006 | CA2594709A1 Intravenous formulations of pde-5 inhibitors |
| 07/20/2006 | CA2575522A1 Novel hydrogels and uses thereof |
| 07/19/2006 | EP1681354A2 Recombinant viruses coding for a glutamate decarboxylase (gad) |
| 07/19/2006 | EP1681300A1 Hybrid tetanus toxoid proteins that migrate retrogradely and transynaptically into the CNS |
| 07/19/2006 | EP1681065A1 Water-based composition undergoing reversible thermogelation |
| 07/19/2006 | EP1681051A1 Multi-layer controlled-release tablet comprising an active layer and one or more barrier layers |
| 07/19/2006 | EP1681046A2 Cosmetic, pharmaceutical and dermatological compositions containing copolymer waxes |
| 07/19/2006 | EP1680963A1 Cocoa components, edible products having enhanced polyphenol content, methods of making same and medical uses |
| 07/19/2006 | EP1680472A2 Compounds for dual photodiagnosis and therapy |
| 07/19/2006 | EP1680148A1 Hydrogel-containing medical articles and methods of using and making the same |
| 07/19/2006 | EP1680142A2 Thermosensitive, biocompatible polymer carriers with a variable physical structure for treatment, diagnosis and analysis |
| 07/19/2006 | EP1680138A1 Combination therapy |
| 07/19/2006 | EP1680134A1 Compositions and uses therof |
| 07/19/2006 | EP1680130A2 Desensitization of complement activation using monocyte/macrophage inhibitory compounds |
| 07/19/2006 | EP1680129A2 Inosine monophosphate dehydrogenase inhibitors as phosphonate derivatives |
| 07/19/2006 | EP1680100A1 Compositions of quaternary ammonium containing bioavailability enhancers |
| 07/19/2006 | EP1680097A1 Preparations for topical application and methods of delivering an active agent to a substrate |
| 07/19/2006 | EP1680087A1 Nanoparticles for drug delivery |
| 07/19/2006 | EP1680085A1 A novel cationic lipopolymer as a biocompatible gene delivery agent |
| 07/19/2006 | EP1680084A2 A multiple route medication for the treatment of rhinitis and asthma |
| 07/19/2006 | EP1680083A1 Compositions and dosage forms for ehnanced absorption of iron |
| 07/19/2006 | EP1680082A1 Compositions and dosage forms for enhanced absorption of metformin |
| 07/19/2006 | EP1680079A2 Rapidly disintegrating films for delivery of pharmaceutical or cosmetic agents |
| 07/19/2006 | EP1680078A2 Oral matrix formulations of doxazosin |
| 07/19/2006 | EP1680076A1 Pharmaceutical and cosmetic formulations for treating fingernails |
| 07/19/2006 | EP1680073A2 Compounds and method for treating cancer |
| 07/19/2006 | EP1680057A2 Apparatus and method for enhancing transdermal drug delivery |
| 07/19/2006 | EP1594483B1 Uv stable transdermal therapeutic plaster |
| 07/19/2006 | EP1463488B1 Pharmaceutical composition comprising skimmed milk powder |
| 07/19/2006 | EP1395273B1 Targeted delivery of drugs for the treatment of viral infections |
| 07/19/2006 | EP1389137B1 Compositions for protein delivery via the pulmonary route |
| 07/19/2006 | EP1368045B1 Process for obtention of decoctions of vitis labrusca and vitis vinifera skins |
| 07/19/2006 | EP1323417B1 Tablets quickly disintegrating in the oral cavity and process for producing the same |
| 07/19/2006 | EP1289502B1 Microemulsion preconcentrates, microemulsion and use of such a composition |
| 07/19/2006 | EP1283725B1 Solid dispersion system of pranlukast with improved dissolution, and the preparing method thereof |
| 07/19/2006 | EP1282399B1 Rapidly disintegrating solid oral dosage form |
| 07/19/2006 | EP1164991A4 Gels formed by the interaction of poly(aldehyde) with various substances |
| 07/19/2006 | EP1121109B8 Biphasic tramadol preparation |
| 07/19/2006 | EP1015561B1 In vitro method for disassembly/reassembly of papillomavirus virus-like particles (vlps) |
| 07/19/2006 | EP0966481B1 Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics |
| 07/19/2006 | EP0831923B1 Separation of active complexes |